UBS Group
CVS icon

UBS Group’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$459M Sell
6,658,180
-1,747,737
-21% -$121M 0.08% 206
2025
Q1
$570M Sell
8,405,917
-1,508,924
-15% -$102M 0.1% 164
2024
Q4
$445M Buy
9,914,841
+3,613,845
+57% +$162M 0.08% 183
2024
Q3
$396M Sell
6,300,996
-734,006
-10% -$46.2M 0.09% 177
2024
Q2
$415M Sell
7,035,002
-1,027,078
-13% -$60.7M 0.1% 157
2024
Q1
$643M Buy
8,062,080
+732,562
+10% +$58.4M 0.16% 100
2023
Q4
$579M Sell
7,329,518
-364,616
-5% -$28.8M 0.17% 95
2023
Q3
$537M Sell
7,694,134
-842,844
-10% -$58.8M 0.19% 90
2023
Q2
$590M Buy
8,536,978
+1,563,275
+22% +$108M 0.2% 91
2023
Q1
$518M Sell
6,973,703
-353,723
-5% -$26.3M 0.19% 96
2022
Q4
$683M Buy
7,327,426
+913,885
+14% +$85.2M 0.26% 66
2022
Q3
$612M Sell
6,413,541
-907,766
-12% -$86.6M 0.27% 64
2022
Q2
$678M Buy
7,321,307
+198,472
+3% +$18.4M 0.28% 64
2022
Q1
$721M Sell
7,122,835
-111,574
-2% -$11.3M 0.24% 75
2021
Q4
$746M Sell
7,234,409
-92,005
-1% -$9.49M 0.21% 79
2021
Q3
$622M Sell
7,326,414
-730,840
-9% -$62M 0.2% 86
2021
Q2
$672M Sell
8,057,254
-67,811
-0.8% -$5.66M 0.22% 82
2021
Q1
$611M Buy
8,125,065
+528,955
+7% +$39.8M 0.2% 85
2020
Q4
$519M Buy
7,596,110
+828,301
+12% +$56.6M 0.18% 98
2020
Q3
$395M Sell
6,767,809
-747,479
-10% -$43.7M 0.15% 114
2020
Q2
$488M Sell
7,515,288
-572,176
-7% -$37.2M 0.21% 94
2020
Q1
$480M Buy
8,087,464
+762,010
+10% +$45.2M 0.23% 82
2019
Q4
$544M Buy
7,325,454
+266,827
+4% +$19.8M 0.19% 100
2019
Q3
$445M Sell
7,058,627
-1,270,153
-15% -$80.1M 0.17% 110
2019
Q2
$454M Buy
8,328,780
+2,404,427
+41% +$131M 0.17% 115
2019
Q1
$320M Buy
5,924,353
+1,242,484
+27% +$67M 0.13% 145
2018
Q4
$307M Buy
4,681,869
+643,514
+16% +$42.2M 0.14% 138
2018
Q3
$318M Sell
4,038,355
-206,131
-5% -$16.2M 0.13% 149
2018
Q2
$273M Buy
4,244,486
+316,137
+8% +$20.3M 0.12% 159
2018
Q1
$244M Sell
3,928,349
-1,259,847
-24% -$78.4M 0.11% 166
2017
Q4
$376M Sell
5,188,196
-6,395,374
-55% -$464M 0.15% 125
2017
Q3
$942M Buy
11,583,570
+454,492
+4% +$37M 0.44% 26
2017
Q2
$895M Buy
11,129,078
+475,396
+4% +$38.3M 0.46% 26
2017
Q1
$836M Buy
10,653,682
+1,455,785
+16% +$114M 0.46% 26
2016
Q4
$726M Buy
9,197,897
+2,728,362
+42% +$215M 0.4% 30
2016
Q3
$576M Buy
6,469,535
+168,673
+3% +$15M 0.34% 44
2016
Q2
$603M Buy
6,300,862
+220,785
+4% +$21.1M 0.38% 31
2016
Q1
$631M Buy
6,080,077
+225,846
+4% +$23.4M 0.42% 30
2015
Q4
$572M Buy
5,854,231
+962,840
+20% +$94.1M 0.37% 39
2015
Q3
$472M Buy
4,891,391
+458,052
+10% +$44.2M 0.33% 41
2015
Q2
$465M Buy
4,433,339
+248,994
+6% +$26.1M 0.31% 52
2015
Q1
$432M Buy
4,184,345
+229,657
+6% +$23.7M 0.3% 61
2014
Q4
$381M Buy
+3,954,688
New +$381M 0.27% 65